Eosinophilic gastroenteritis is a rare disease, characterized by eosinophilic infiltrates in the intestinal layers. Its etiology is not well known. A biopsy is mandatory for accurate diagnosis. Clinical presentation is variable and can be seen in numerous diseases. There are no pathognomonic findings. Serosal-type involvement is the rarest and usually is associated with ascites. In this case, we report a 21-year-old female patient presented with abdominal pain, diarrhoea, vomiting and ascites. Diagnosis of eosinophilic gastroenteritis was made after eliminating broad-spectrum mimicking causes of tissue eosinophilia. The patient recovered completely after treatment with steroids.
Colorectal cancer ranks third among all cancers in terms of prevalence. It is the second most common cause of death overall. The patterns of spread are lymphatic, hematogenous, and direct invasion. Lymph node involvement is a prognostic factor and has a strong correlation with survival and disease free interval. Regional lymph nodes are frequently the first structures to get affected. Metastatic disease (stage IV) is defined as the spread of disease to lymph nodes other than regional ones. Because of this, the type of treatment that is administered and the patient's survival rate are both affected when the cancer spreads to non-regional lymph nodes. In this particular instance, we report a patient who had results that were consistent with having a pancreatic tumor. Nevertheless, with the aid of endoscopic ultrasonography, we determined that the patient had metastatic colon cancer. And the patient's trajectory takes a dramatic turn for the worse, shifting from resectable pancreatic cancer to metastatic colon cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.